EWS-ERG fusion transcript produced by chromosomal insertion in a Ewing sarcoma

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Ewing sarcoma-like tumors often involve fusions between the EWS gene and ETS-family genes.
• The EWS-ERG fusion transcript is found in about 10% of Ewing-family tumors.
• Specific chromosomal translocations, like t(21;22)(q22;q12), are typically identified by cytogenetics.

Purpose of the Study:

• To investigate the mechanism behind EWS-ERG fusion in a tumor that lacked typical cytogenetic findings.
• To characterize a novel chromosomal aberration leading to gene fusion.
• To explore potential common pathways for gene fusions in cancers.

Main Methods:

• Karyotyping to analyze the tumor's chromosomal composition.
• Reverse transcriptase-polymerase chain reaction (RT-PCR) to detect the EWS-ERG fusion transcript.
• Fluorescence in situ hybridization (FISH) to visualize gene locations and confirm fusion.

Main Results:

• A complex karyotype (50, XY, +8, +8, +12, +mar) was identified.
• RT-PCR and sequencing confirmed the presence of the EWS-ERG fusion transcript.
• FISH analysis revealed an inversion/insertion of EWS onto chromosome 21, fusing with ERG.

Conclusions:

• A subtle chromosomal inversion/insertion, not detectable by routine cytogenetics, generated the EWS-ERG fusion.
• This mechanism of fusing reverse-oriented genes may be a common pathway in both leukemias and solid tumors.
• Detailed molecular and cytogenetic analyses are essential for identifying complex chromosomal aberrations.